Stereotactic Radiosurgery for an Unresectable Jugulotympanic Paraganglioma: Clinical Response and Acute Toxicity in a 70-Year-Old Patient

Jugulotympanic paragangliomas (JTPs) are rare, highly vascular neuroendocrine tumors characterized by slow but locally aggressive growth at the skull base. Their management in elderly patients is particularly challenging because of their close proximity to critical neurovascular structures....

Continue reading at PubMed →

This single case report provides limited evidence; audiologists managing patients with jugulotympanic paragangliomas should be aware that stereotactic radiosurgery is a reported non-surgical option, but clinical decisions should rely on established multidisciplinary guidelines rather than this single case.

Jugulotympanic paragangliomas frequently present with pulsatile tinnitus and conductive hearing loss, making awareness of emerging treatment options like stereotactic radiosurgery directly relevant to audiologists involved in patient referral and monitoring.

1. 01A 70-year-old patient with an unresectable jugulotympanic paraganglioma was treated with stereotactic radiosurgery.
2. 02Jugulotympanic paragangliomas are rare tumors near the middle ear and skull base, often causing hearing loss and tinnitus.
3. 03The case documents both clinical response (tumor control) and acute toxicity (short-term side effects) from the radiation.
4. 04Surgical removal was not possible in this patient, making radiosurgery the primary treatment option.
5. 05Evidence is limited to a single case report (N=1); broader conclusions cannot be drawn.

PMID

42924231

DOI

10.7759/cureus.116729.

Journal

Cureus

Publication type

case_report

Evidence level

4

Sample size

1

Population

Single 70-year-old patient with an unresectable jugulotympanic paraganglioma

Intervention

Stereotactic radiosurgery